Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sudeep PharmaBOM:544619 -1.10%18 Gross Margin % is 59.65% as of Mar. 2026, which is 5% below its 10-year median of 62.61. GuruFocus rates BOM:544619 with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 943 Drug Manufacturers companies, Sudeep Pharma ranks better than 73.28% on this metric.
The historical rank and industry rank for Sudeep Pharma's Gross Margin % or its related term are showing as below:
BOM:544619'
s Gross Margin % Range Over the Past 10 Years
Min: 55.7 Med: 62.61 Max: 65.37
Current: 62.94
During the past 4 years, the highestGross Margin % of Sudeep Pharma was 65.37%. The lowest was 55.70%. And the median was 62.61%.
BOM:544619's Gross Margin % is ranked better than 73.28% of 943
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs BOM:544619: 62.94
Sudeep Pharma had a gross margin of 59.65% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Sudeep Pharma was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sudeep Pharma had a gross margin of 59.65% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sudeep Pharma Gross Margin % Related Terms
Sudeep Pharma Gross Margin % Historical Data
* Premium members only.
The historical data trend for Sudeep Pharma's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sudeep Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sudeep Pharma Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sudeep Pharma's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sudeep Pharma's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sudeep Pharma (BOM:544619) has a Gross Margin % of 59.65% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Sudeep Pharma and its competitors. This is near median its historical median of 62.61. Over the past decade, Sudeep Pharma's Gross Margin % has ranged from 55.70 to 65.37. According to the industry distribution chart, Sudeep Pharma ranks #252 out of 943 companies in the Drug Manufacturers industry, placing it in the top 26.7%.
Is Sudeep Pharma's Gross Margin % too high?
Sudeep Pharma's current Gross Margin % of 59.65% is near median its 10-year median of 62.61. Over the past 10 years, this metric has ranged from a low of 55.70 to a high of 65.37. The Drug Manufacturers industry median Gross Margin % is 48.54. Sudeep Pharma's value of 59.65% is 22.9% above this industry median. Based on the distribution chart, Sudeep Pharma ranks #252 out of 943 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sudeep Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sudeep Pharma's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sudeep Pharma ranks #252 out of 943 companies for Gross Margin %. This puts Sudeep Pharma in the upper half of its industry. The industry median Gross Margin % is 48.54. Sudeep Pharma's value of 59.65% is 22.9% above this benchmark. Historically, Sudeep Pharma's own Gross Margin % has ranged from 55.70 to 65.37 over the past decade. While the company's 10-year median is 62.61 vs. the industry median of 48.54, Sudeep Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sudeep Pharma's current Gross Margin % of 59.65% is 22.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sudeep Pharma and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sudeep Pharma's current Gross Margin % is 59.65%, which is near median its own 10-year median of 62.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudeep Pharma stock overvalued right now?
Sudeep Pharma (BOM:544619) has a current Gross Margin % of 59.65%. The current Gross Margin % is 59.65%, which is near median its 10-year median of 62.61 and 22.9% above the Drug Manufacturers industry median of 48.54. Sudeep Pharma's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sudeep Pharma (BOM:544619), the current Gross Margin % is 59.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare ecosystem. The company operates in two business verticals: Pharmaceutical, food, and nutrition. It focuses on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries and Specialty ingredients: It pertains manufacturing of specialty ingredients using advance technology solutions. The maximum revenue is generated from the Pharmaceutical, food, and nutrition segment. Geographically, it has presence in the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
18GF Score
Get the complete analysis for BOM:544619
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544619 has been successfully added to your 
